Dr Le will be responsible for medical and clinical affairs, and will have an advisory role to senior management and the board of directors
The Regenerative Medicine Institute of Canada (RMIC) has announced the appointment of Dr Adrian Le as its Chief Medical Officer.
Dr Le has written several academic publications on the use of platelet-rich plasma (PRP) and other orthobiologic therapies to treat musculoskeletal conditions, such as osteoarthritis. Dr. Le was also the lead author of the book chapter on orthobiologics for DeLee, Drez and Miller's Orthopaedic Sports Medicine (5th Edition), one of the most widely used textbooks in the field.
He completed his residency at the University of Toronto, before going on to complete his sub-specialisation fellowship at Stanford.
"It is a great pleasure to be joining the Regenerative Medicine Institute of Canada to further the innovation of orthobiologics and regenerative medicine in Canada. My personal goal, especially with the not-for-profit team at CBORM, has always been centred on advocating for the ethical practice of orthobiologics. Joining RMIC is an exciting opportunity to further that mission," said Dr Le. "RMIC has demonstrated a commitment to ensuring best-in-class quality of care in the field of orthobiologics, with a keen eye on regulatory compliance. This commitment was clearly demonstrated in their accreditation partnership with CBORM, ensuring that Canadians seeking orthobiologic and regenerative medicine treatments receive care that is of the highest possible standard from our physicians and clinics."